欧盟评估转基因地衣芽孢杆菌菌株DSM 34099出产的β-半乳糖苷酶的平安性时候：2024-08-08 10:39来历：食物火伴网作者： 泽夕 焦点提醒：2024年8月7日，欧盟食物平安局就一种β-半乳糖苷酶 （β-galactosidase）的平安性评价发布定见。 食物火伴网讯 2024年8月7日，欧盟食物平安局就一种 -半乳糖苷酶 （ -galactosidase）的平安性评价发布定见。 据领会，这类食物酶是由转基因地衣芽孢杆菌菌株DSM 34099出产的，旨在用在两种食物出产进程。 颠末评估，专家小组认为，在预期的利用前提下，不克不及解除饮食表露引发过敏反映的风险，特别是对猕猴桃过敏的人。按照所供给的数据，评估小组得出结论，这类食物酶在预期利用前提下不会引发平安问题。部门原文报导以下： The food enzyme -galactosidase ( -d-galactoside galactohydrolase; EC 3.2.1.23) is produced with the genetically modified Bacillus licheniformis strain DSM 34099 by Kerry Group Services International, Ltd. (KGSI). The genetic modifications do not give rise to safety concerns. The food enzyme is free from viable cells of the production organism and its DNA. The production strain met the requirements for the qualified presumption of safety (QPS) approach. The food enzyme is intended to be used in two food manufacturing processes. Dietary exposure was estimated to be up to 7.263 mg total organic solids/kg body weight per day in European populations. Given the QPS status of the production strain and the absence of concerns resulting from the food enzyme manufacturing process, toxicity tests, other than an assessment of allergenicity, were considered unnecessary by the Panel. A search for the identity of the amino acid sequence of the food enzyme to known allergens was made and one match with a food allergen from kiwi fruit was found. The Panel considered that a risk of allergic reactions upon dietary exposure to this food enzyme, particularly in individuals sensitised to kiwi fruit, cannot be excluded. based on the data provided, the Panel concluded that this food enzyme does not give rise to safety concerns, under the intended conditions of use. 本文由食物火伴网食物资讯中间编纂，有任何疑问，请联系news@foodmate.net。